https://www.onconano.com/press-releases daily 0.75 2026-01-05 https://www.onconano.com/press-releases/onconano-medicine-announces-research-collaboration-with-gilead-to-apply-on-board-delivery-technology-to-gileads-drug-candidate monthly 0.5 2026-01-06 https://www.onconano.com/press-releases/onconano-announces-appointment-of-brent-sorrells-as-chief-operating-officer monthly 0.5 2025-11-17 https://www.onconano.com/press-releases/onconano-medicine-announces-presentation-at-aacr-nic-eortc-international-conference-on-molecular-targets-and-cancer-therapeutics-tt7jl monthly 0.5 2025-10-27 https://www.onconano.com/press-releases/onconano-medicine-announces-presentation-at-aacr-nic-eortc-international-conference-on-molecular-targets-and-cancer-therapeutics monthly 0.5 2025-10-15 https://www.onconano.com/press-releases/onconano-medicine-presents-preclinical-data-for-on-board-il-12-program-at-aacr-annual-meeting-2024-48y44 monthly 0.5 2024-12-03 https://www.onconano.com/press-releases/onconano-medicine-presents-preclinical-data-for-on-board-il-12-program-at-aacr-annual-meeting-2024 monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-medicine-to-present-late-breaking-poster-at-the-american-association-for-cancer-research-aacr-annual-meeting-2024 monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-medicine-appoints-kartik-krishnan-as-chief-executive-officer-and-promotes-melissa-paoloni-to-chief-operating-officer monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-medicine-announces-first-patient-dosed-in-phase-1-study-evaluating-onm-501-in-patients-with-advanced-solid-tumors-and-lymphomas monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-medicine-announces-promotion-of-kartik-krishnan-md-phd-to-president-and-head-of-research-development monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-medicine-announces-positive-preclinical-data-for-on-board-il-12-program-at-sitc-2023-annual-meeting monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-medicine-to-present-preclinical-data-for-on-board-platform-at-the-society-for-immunotherapy-of-cancer-sitc-annual-meeting monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-and-regeneron-enter-into-clinical-trial-supply-agreement-for-use-of-libtayo-cemiplimab-in-onm-501-study monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-medicine-presents-positive-final-results-from-phase-2-trial-of-pegsitacianine-in-podium-presentation-at-2023-asco-annual-meeting monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-medicine-announces-oral-presentation-at-the-american-society-of-clinical-oncology-asco-annual-meeting-2023 monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-presents-compelling-data-for-onm-501-and-a-novel-tumor-specific-delivery-technology-at-aacr-annual-meeting-2023 monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-medicine-presents-data-from-phase-2-pegsitacianine-study-at-society-of-surgical-oncology-sso-2023-international-congress-on-surgical-cancer-care monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-medicine-to-present-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023 monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-medicines-pegsitacianine-granted-breakthrough-therapy-designation-for-real-time-surgical-imaging-by-the-food-and-drug-administration monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-medicine-announces-new-preclinical-data-for-on-board-platform-for-delivery-of-bispecific-t-cell-engagers-and-a-therapeutic-cytokine-at-the-society-for-immunotherapy-of-cancer-sitc monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-medicine-announces-pre-clinical-data-for-dual-activating-sting-agonist-at-the-society-for-immunotherapy-of-cancer-sitc-annual-meeting monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-medicine-to-present-data-on-novel-development-candidates-at-the-society-for-immunology-of-cancer-sitc-annual-meeting monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-medicine-announces-positive-phase-2-data-for-pegsitacianine-as-an-adjunct-to-cytoreductive-surgery-of-peritoneal-carcinomatosis monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-medicine-to-present-at-cantor-fitzgerald-oncology-hemonc-conference monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-medicine-announces-oral-presentation-of-phase-2-study-data-at-the-world-molecular-imaging-congress-2022 monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-medicine-appoints-kartik-krishnan-m-d-ph-d-as-chief-medical-officer monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-medicine-announces-the-appointment-of-elina-lavit-as-vice-president-business-development monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-medicine-announces-positive-preclinical-data-for-onm-501-at-aacr-2022-annual-meeting monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-medicine-announces-positive-preclinical-data-for-tumor-specific-delivery-with-the-on-board-platform-at-aacr-2022-annual-meeting monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-medicine-to-present-at-the-american-association-for-cancer-research-aacr-annual-meeting-2022 monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-medicine-appoints-brett-giroir-m-d-to-board-of-directors monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-announces-18-4-million-equity-investment-by-the-cancer-prevention-and-research-institute-of-texas monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/pegsitacianine-demonstrates-tumor-agnostic-real-time-surgical-imaging-in-phase-2-study monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/positive-preclinical-data-for-onm-501-at-aacr-virtual-conference monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-medicine-to-present-at-the-american-association-for-cancer-research-virtual-conference-on-tumor-immunology-and-immunotherapy monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-medicine-announces-expanded-research-collaboration-with-ut-southwestern-medical-center-to-advance-development-of-new-cancer-therapies monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-medicine-to-present-at-the-world-molecular-imaging-congress monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-medicine-raises-50-million-in-series-b-financing monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-medicine-to-present-at-the-2nd-annual-lifesci-partners-private-company-summer-symposium-2 monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-medicine-raises-50-million-in-series-b-financing-2 monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-awarded-15-4-million-grant-from-cancer-prevention-and-research-institute-of-texas monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-announces-publication-of-onm-100-phase-1-data-in-nature-communications monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/study-reveals-compelling-data-for-a-new-nanoparticle-based-immuno-therapeutic-to-treat-cancer-2 monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/study-reveals-compelling-data-for-a-new-nanoparticle-based-immuno-therapeutic-to-treat-cancer monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-medicine-announces-martin-driscoll-as-chief-executive-officer monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/november-2020-onconano-announces-positive-preclinical-data-for-onm-400-tumor-specific-il-2-delivery-at-the-2020-society-for-immunotherapy-of-cancer-sitc-annual-meeting monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/october-2020-onconano-announces-positive-clinical-data-for-cancer-imaging-agent-onm-100-at-the-world-molecular-imaging-congress-cEdrH monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-awarded-9-97-million-grant-from-cancer-prevention-and-research-institute-of-texas monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-announces-publication-of-onm-100-phase-1-data-in-nature-communications-2 monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-announces-presentations-at-the-2019-sitc-annual-meeting monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onm-100-to-be-featured-in-presentation-at-world-molecular-imaging-congress-2019 monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-awarded-15-4-million-grant-from-cancer-prevention-and-research-institute-of-texas-2 monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-closes-additional-23-7-million-in-second-tranche-of-series-a-financing-bringing-total-series-a-raise-to-35-4-million monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-to-present-poster-on-first-in-human-study-of-ph-activated-platform-for-detection-of-solid-tumors-during-surgery-at-2019-asco-annual-meeting monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-receives-authorization-to-proceed-from-fda-for-ind-application-and-fast-track-designation-for-onm-100-intraoperative-imaging-agent-to-detect-tumors-and-metastatic-lymph-nodes-that-often-go-u monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-announces-completion-of-phase-1a-study-and-expands-into-phase-1b-for-intraoperative-imaging-agent-to-detect-tumors-and-metastatic-lymph-nodes-that-often-go-undetected-during-surgery monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconanoannounces-dosing-of-patientsin-phase-1-clinical-trial-with-onm-100-an-intraoperative-imaging-agent-that-targets-tumor-acidosisforthe-detection-of-solid-tumors monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/onconano-announces-11-7-million-series-a-financing-to-support-development-of-ph-activated-compound-platform-for-disease-detection-and-treatment monthly 0.5 2024-05-28 https://www.onconano.com/press-releases/category/Publications monthly 0.5 https://www.onconano.com/press-releases/category/News monthly 0.5 https://www.onconano.com/press-releases/category/Press+Releases monthly 0.5 https://www.onconano.com/publications daily 0.75 2025-10-29 https://www.onconano.com/publications/results-from-part-1-of-on-5001 monthly 0.5 2025-10-29 https://www.onconano.com/publications/detection-of-residual-peritoneal-mets-final-2-phase-results-3sdhl monthly 0.5 2025-10-29 https://www.onconano.com/publications/detection-of-residual-peritoneal-mets-final-2-phase-results monthly 0.5 2024-05-17 https://www.onconano.com/publications/preclinical-characterization-of-onm-412-an-ultra-ph-sensitive-nanoparticle-encapsulated-il-12-fusion-protein monthly 0.5 2026-02-09 https://www.onconano.com/publications/encapsulation-of-il-12-with-an-ultra-ph-sensitive-tumor-delivery-platform-improves-tolerability-and-promotes-antitumor-response-in-a-preclinical-model monthly 0.5 2026-02-09 https://www.onconano.com/publications/encapsulation-of-il-12-with-an-ultra-ph-sensitive-nanoparticle-platform-improves-tolerability-and-promotes-antitumor-response-in-mice monthly 0.5 2026-02-09 https://www.onconano.com/publications/improved-tolerability-and-tumor-specific-delivery-of-a-therapeutic-bispecific-t-cell-engager-using-a-ph-sensitive-nanoparticle-platform monthly 0.5 2024-05-17 https://www.onconano.com/publications/onm-501-a-dual-activating-polyvalent-sting-agonist-enhances-tumor-retention-and-demonstrates-favorable-preclinical-safety-profile monthly 0.5 2024-05-17 https://www.onconano.com/publications/a-clinically-validated-ph-sensitive-nanomedicine-platform-for-encapsulating-therapeutic-bispecific-t-cell-engagers-for-tumor-specific-delivery-and-activation monthly 0.5 2024-05-17 https://www.onconano.com/publications/a-polyvalent-sting-agonist-exhibits-anti-tumor-efficacy-with-increased-tumor-t-cell-infiltration-in-mice-and-is-well-tolerated-in-rats-and-non-human-primates monthly 0.5 2024-05-17 https://www.onconano.com/publications/onm-501-a-polyvalent-sting-agonist-for-oncology-immunotherapy monthly 0.5 2024-05-17 https://www.onconano.com/publications/encapsulating-therapeutic-antibodies-for-tumor-specific-activation-and-delivery-using-a-clinically-validated-ph-sensitive-nanoparticle-platform monthly 0.5 2024-05-17 https://www.onconano.com/publications/prolonged-activation-of-innate-immune-pathways-by-a-polyvalent-sting-agonist monthly 0.5 2024-05-17 https://www.onconano.com/publications/exploiting-nanoscale-cooperativity-for-precision-medicine monthly 0.5 2024-05-17 https://www.onconano.com/publications/exploiting-metabolic-acidosis-in-solid-cancers-using-a-tumor-agnostic-ph-activatable-nanoprobe-for-fluorescence-guided-surgery monthly 0.5 2024-05-17 https://www.onconano.com/publications/pet-imaging-of-occult-tumours-by-temporal-integration-of-tumour-acidosis-signals-from-ph-sensitive-64cu-labelled-polymers-nat-bme-huang-2020-314-324 monthly 0.5 2024-05-17 https://www.onconano.com/publications/image-guided-surgery-for-tumor-agnostic-detection-of-solid-tumors-using-the-ph-activated-micellar-imaging-agent-onm-100 monthly 0.5 2024-05-17 https://www.onconano.com/publications/transistor-like-ultra-ph-sensitive-polymeric-nanoparticles monthly 0.5 2024-05-17 https://www.onconano.com/publications/investigation-of-endosome-and-lysosome-biology-by-ultra-ph-sensitive-nanoprobes monthly 0.5 2024-05-17 https://www.onconano.com/publications/a-transistor-like-ph-nanoprobe-for-tumour-detection-and-image-guided-surgery monthly 0.5 2024-05-17 https://www.onconano.com/publications/digitization-of-endocytic-ph-by-hybrid-ultra-ph-sensitive-nanoprobes-at-single-organelle-resolution monthly 0.5 2024-05-17 https://www.onconano.com/publications/molecular-basis-of-cooperativity-in-ph-triggered-supramolecular-self-assembly monthly 0.5 2024-05-17 https://www.onconano.com/publications/ultra-ph-sensitive-nanoprobe-library-with-broad-ph-tunability-and-fluorescence-emissions-jacs-ma-2014 monthly 0.5 2024-05-17 https://www.onconano.com/publications/category/ON-BOARD%E2%84%A2 monthly 0.5 https://www.onconano.com/publications/category/Pegsitacianine monthly 0.5 https://www.onconano.com/publications/category/ONM-100 monthly 0.5 https://www.onconano.com/publications/category/IL-12 monthly 0.5 https://www.onconano.com/publications/category/ONM-412 monthly 0.5 https://www.onconano.com/publications/category/ONM-501 monthly 0.5 https://www.onconano.com/home daily 1.0 2026-01-06 https://images.squarespace-cdn.com/content/v1/6616b29e6e6a4d21ed180f10/387aece8-4921-4a28-952c-1a9d239643bc/Image+12.png https://images.squarespace-cdn.com/content/v1/6616b29e6e6a4d21ed180f10/38b9cd5e-8098-4cc8-a359-5ea723a4db9d/Onconano_Website+Technology+Band5.png https://images.squarespace-cdn.com/content/v1/6616b29e6e6a4d21ed180f10/27f3a671-26fc-4e78-a1b3-1a754bcf11c5/Onconano_Website+Technology+Band.png https://www.onconano.com/about daily 0.75 2025-10-08 https://images.squarespace-cdn.com/content/v1/6616b29e6e6a4d21ed180f10/1715774853201-BYVOPW12ARIWPFDH6RVS/Krishnan+Headshot.jpg ABOUT US - <strong>Kartik Krishnan, MD, PhD</strong> Chief Executive Officer https://images.squarespace-cdn.com/content/v1/6616b29e6e6a4d21ed180f10/1762869134050-ECQ9ZSTB5WS5NBTKVW6U/Brent-Sorrells-1.jpg ABOUT US - <strong>Brent Sorrells</strong> Chief Operating Officer https://images.squarespace-cdn.com/content/v1/6616b29e6e6a4d21ed180f10/34da8819-6e5e-4724-b0e4-c7c1a208c82c/Matthew-Head.jpg ABOUT US - <strong>Matthew Head, MBA</strong> Chief Financial Officer https://images.squarespace-cdn.com/content/v1/6616b29e6e6a4d21ed180f10/5100bb37-d0a5-485c-898a-74f24a467aae/Tian-Zhao.jpg ABOUT US - <strong>Tian Zhao, PhD</strong> Vice President, Research and Development https://images.squarespace-cdn.com/content/v1/6616b29e6e6a4d21ed180f10/a34d69dd-b874-4d65-abaf-e4bc455131a2/Ruolan-Han.jpg ABOUT US - <strong>Ruolan Han, PhD</strong> Vice President, Nonclinical and Translational Medicine https://images.squarespace-cdn.com/content/v1/6616b29e6e6a4d21ed180f10/1715796204226-PVYI5F8QF0O82I2CTJG3/Dean+Hodgson.jpg ABOUT US - <strong>Dean Hodgson</strong> Vice President, Technical Operations https://www.onconano.com/partnering daily 0.75 2025-10-29 https://images.squarespace-cdn.com/content/v1/6616b29e6e6a4d21ed180f10/8ad176f4-ba7e-4343-9034-c3ceff9463a5/Partnership+Banner_042624%401.25x.jpg https://images.squarespace-cdn.com/content/v1/6616b29e6e6a4d21ed180f10/606f4370-6005-4a9a-80ca-2d2e0c1d7230/Partnership+Banner3%401.5x.jpg https://www.onconano.com/contact-us daily 0.75 2024-04-10 https://www.onconano.com/ui-kit daily 0.75 2024-04-16 https://images.squarespace-cdn.com/content/v1/6616b29e6e6a4d21ed180f10/b79fa8d2-4c3b-4d3e-bd2e-f029afd2be17/Onconano_Brand+Guide_v8.png https://www.onconano.com/technology-overview-2 daily 0.75 2024-06-08 https://images.squarespace-cdn.com/content/v1/6616b29e6e6a4d21ed180f10/4d301dfc-4be8-4559-a0b0-45fffcd85e95/Onconano_Website%2BArtwork_060724-20.png https://www.onconano.com/technology-overview-3 daily 0.75 2026-03-02 https://images.squarespace-cdn.com/content/v1/6616b29e6e6a4d21ed180f10/6c8100c8-2e0c-41f7-a58a-62544e6ef8b3/Onconano_Pipeline_030126.png https://images.squarespace-cdn.com/content/v1/6616b29e6e6a4d21ed180f10/170ffd07-46d9-43c6-a3dd-37293f8b075a/Image+6.png https://www.onconano.com/technology-overview-4 daily 0.75 2024-05-17 https://images.squarespace-cdn.com/content/v1/6616b29e6e6a4d21ed180f10/cbb99d7b-aa8b-4140-b114-667034726365/Image+1.png https://images.squarespace-cdn.com/content/v1/6616b29e6e6a4d21ed180f10/8131c6d6-b795-4627-9a1b-0010c1820a13/Image+2.png https://images.squarespace-cdn.com/content/v1/6616b29e6e6a4d21ed180f10/7d501783-0bf3-49d6-95d8-588446c6baf1/Image+3.png https://images.squarespace-cdn.com/content/v1/6616b29e6e6a4d21ed180f10/3349399a-74c3-4b0a-af14-22bbb01f5e77/Image+5.png https://www.onconano.com/technology-overview-5 daily 0.75 2024-06-07 https://images.squarespace-cdn.com/content/v1/6616b29e6e6a4d21ed180f10/38128793-a2a4-4bc8-af6c-d3d554d67032/Onconano_Website%2BArtwork_060724-22.png https://images.squarespace-cdn.com/content/v1/6616b29e6e6a4d21ed180f10/84b8c348-ef30-47db-933d-112df79c0e6a/Image+8.png https://images.squarespace-cdn.com/content/v1/6616b29e6e6a4d21ed180f10/ed6d3ff1-3c2d-4d26-b4df-1e737ac05a2a/image+9.png https://www.onconano.com/technology-overview-7lrcy daily 0.75 2024-05-17 https://www.onconano.com/technology-overview-88d8z daily 0.75 2024-05-13 https://www.onconano.com/kartik-krishnan-md-phd daily 0.75 2024-05-16 https://images.squarespace-cdn.com/content/v1/6616b29e6e6a4d21ed180f10/1715774853201-BYVOPW12ARIWPFDH6RVS/Krishnan+Headshot.jpg https://www.onconano.com/matthew-head-mba daily 0.75 2024-05-22 https://images.squarespace-cdn.com/content/v1/6616b29e6e6a4d21ed180f10/34da8819-6e5e-4724-b0e4-c7c1a208c82c/Matthew-Head.jpg https://www.onconano.com/tian-zhao-phd daily 0.75 2024-05-16 https://images.squarespace-cdn.com/content/v1/6616b29e6e6a4d21ed180f10/5100bb37-d0a5-485c-898a-74f24a467aae/Tian-Zhao.jpg https://www.onconano.com/ruolan-han-phd daily 0.75 2024-05-16 https://images.squarespace-cdn.com/content/v1/6616b29e6e6a4d21ed180f10/a34d69dd-b874-4d65-abaf-e4bc455131a2/Ruolan-Han.jpg https://www.onconano.com/dean-hodgson daily 0.75 2024-05-16 https://images.squarespace-cdn.com/content/v1/6616b29e6e6a4d21ed180f10/1715796204226-PVYI5F8QF0O82I2CTJG3/Dean+Hodgson.jpg https://www.onconano.com/brett-p-giroir-md daily 0.75 2024-05-16 https://www.onconano.com/kartik-krishnan-md-phd/bod daily 0.75 2024-05-22 https://www.onconano.com/john-dyett daily 0.75 2024-05-16 https://www.onconano.com/gina-guillem-jones-mms-phd daily 0.75 2024-05-17 https://www.onconano.com/benjamin-qui-cfa-cma daily 0.75 2024-06-04 https://www.onconano.com/investor-resources daily 0.75 2026-02-19 https://images.squarespace-cdn.com/content/v1/6616b29e6e6a4d21ed180f10/cf9ceb34-7b1d-4788-9725-bc462dbe22eb/Onconano-corp-presentation-thumb.png https://www.onconano.com/press-release daily 0.75 2024-05-21 https://www.onconano.com/publication daily 0.75 2024-05-17 https://www.onconano.com/videos daily 0.75 2024-06-07 https://www.onconano.com/polymer-drug-conjugates daily 0.75 2025-12-10 https://images.squarespace-cdn.com/content/v1/6616b29e6e6a4d21ed180f10/6e7e58aa-b27a-4d15-b608-820cc75a3a8d/Onconano-PDC-for-website-SQUARE.png https://www.onconano.com/brent-sorrells daily 0.75 2026-01-06 https://images.squarespace-cdn.com/content/v1/6616b29e6e6a4d21ed180f10/b31e1c4d-dd1e-49dd-a505-7b1d7a67538b/Brent-Sorrells-1.jpg